BlackRock
DFTX

BlackRock’s Definium Therapeutics DFTX Stock Holding History

BlackRock’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$528M Buy
11,232,834
+2,752,604
+32% +$68M 0.01% 1179
2026
Q1 		$160M Buy
8,480,230
+206,954
+3% +$3.51M ﹤0.01% 1803
2025
Q4 		$111M Buy
8,273,276
+2,337,719
+39% +$28.9M ﹤0.01% 2046
2025
Q3 		$70M Buy
5,935,557
+133,418
+2% +$1.24M ﹤0.01% 2299
2025
Q2 		$37.7M Buy
5,802,139
+86,426
+2% +$568K ﹤0.01% 2624
2025
Q1 		$33.4M Sell
5,715,713
-354,340
-6% -$2.54M ﹤0.01% 2609
2024
Q4 		$42.2M Buy
6,070,053
+406,020
+7% +$2.79M ﹤0.01% 2562
2024
Q3 		$32.2M Buy
5,664,033
+280,003
+5% +$1.95M ﹤0.01% 2734
2024
Q2 		$38.8M Buy
5,384,030
+4,589,718
+578% +$40.1M ﹤0.01% 2574
2024
Q1 		$7.47M Buy
794,312
+243,695
+44% +$1.39M ﹤0.01% 3501
2023
Q4 		$2.02M Buy
550,617
+1,536
+0.3% +$4.63K ﹤0.01% 4037
2023
Q3 		$1.72M Sell
549,081
-4,231
-0.8% -$17.4K ﹤0.01% 4058
2023
Q2 		$1.98M Buy
553,312
+101,320
+22% +$350K ﹤0.01% 4057
2023
Q1 		$1.43M Hold
451,992
– – ﹤0.01% 4203
2022
Q4 		$994K Buy
451,992
+421,478
+1,381% +$1.17M ﹤0.01% 4414
2022
Q3 		$107K Buy
30,514
+16,641
+120% +$160K ﹤0.01% 5158
2022
Q2 		$133K Sell
13,873
-1,081,741
-99% -$13.7M ﹤0.01% 5150
2022
Q1 		$18.2M Sell
1,095,614
-42,091
-4% -$730K ﹤0.01% 3229
2021
Q4 		$23.6M Buy
1,137,705
+25,572
+2% +$816K ﹤0.01% 3177
2021
Q3 		$38.9M Buy
1,112,133
+66,499
+6% +$2.87M ﹤0.01% 2830
2021
Q2 		$54.1M Buy
+1,045,634
New +$54.9M ﹤0.01% 2645

Other funds holding DFTX

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

BlackRock's DFTX Position: Q2 2026 in Review

BlackRock increased its Definium Therapeutics (DFTX) stake by 32% in Q2 2026, buying an estimated $68M and bringing the position to 11,232,834 shares worth $528M. The position accounts for 0.01% of the portfolio, ranked #1179.

BlackRock first reported a position in DFTX in Q2 2021 and has held it in 21 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • BlackRock held 11,232,834 shares of Definium Therapeutics worth $528M as of Q2 2026.
  • BlackRock bought 2,752,604 Definium Therapeutics shares in Q2 2026, an estimated $68M.
  • Definium Therapeutics made up 0.01% of BlackRock's portfolio in Q2 2026, its #1179 holding.
  • BlackRock first reported a position in Definium Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.